Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Aug;11(4):401-24.
doi: 10.1007/BF01058958.

An incremental method for the study of the absorption of drugs whose kinetics are described by a two-compartment model: estimation of the microscopic rate constants

An incremental method for the study of the absorption of drugs whose kinetics are described by a two-compartment model: estimation of the microscopic rate constants

A Gerardin et al. J Pharmacokinet Biopharm. 1983 Aug.

Abstract

A method is proposed for estimating the overall absorption kinetics of drugs (expressed as percent of total amount absorbed versus time) from plasma data. It is applicable to the study of drugs whose kinetics can be described by linear one- or two-compartment models. Use is made of an iterative process based on the differential equations of the model and on linear interpolation of plasma data. The method does not require that the overall absorption kinetics should be apparent first-order and/or that the model parameters should be estimated from a previous experiment. It was tested for the influence of data scatter: added noise (CV = 10%) resulted in a variability of percent absorbed versus time of the same order of magnitude. During the calculations, the microscopic rate constants are estimated and optimalized. Data scatter resulted in wide variations in the estimates of the two-compartment model parameters. However, when a sufficiently large number of plasma concentration-time curves were studied, an average model could be determined with a reasonable precision. Model kinetics calculated from the related parameter estimates were in agreement with the theory. The method permits the exploitation of the various plasma concentration-time curves which are available after the development of an orally administered drug.

PubMed Disclaimer

References

    1. J Pharmacokinet Biopharm. 1982 Feb;10(1):15-26 - PubMed
    1. J Pharm Sci. 1963 Jun;52:610-1 - PubMed
    1. J Pharmacokinet Biopharm. 1983 Aug;11(4):425-33 - PubMed
    1. J Pharmacokinet Biopharm. 1974 Dec;2(6):469-86 - PubMed
    1. J Pharm Pharmacol. 1973 Dec;25:Suppl:44P-51P - PubMed

Substances

LinkOut - more resources